Categories: Press-Releases

Nova Oculus and SEC declare truce in regulatory dispute

[ad_2]

‘I’m happy to have this matter behind us,’ says company CEO

PALM DESERT, Calif., July 10, 2022 /PRNewswire-PRWeb/ — NOVA OCULUS PARTNERS, LLC has reached a settlement with the Securities and Exchange Commission (SEC) that ends the SEC’s enforcement action against the company. The settlement (Case # 5:18-cv-00701-FLA-SPx; U.S. District Court for the Central District of California) stipulates the company will not pay any monetary penalties and agrees only to an injunction not to violate securities laws. Moreover, the company and its officers neither admit nor deny having violated any securities laws.

Company CEO Walter O’Rourke said he is pleased with this resolution of the SEC action. “I’m happy to have this matter finally behind us,” he said. “This settlement allows the company and its investors to move on. There are a lot of exciting new developments in store.”

ABOUT NOVA OCULUS
NOVA OCULUS is the name of the pioneering new medical device engineered and developed to treat the dry form of Age-Related Macular Degeneration—and for the company of innovative people that created it.

The Nova Oculus device holds the potential to revolutionize the treatment protocols for dry AMD and offer hope to millions of North Americans who are going blind without it. Dry AMD is an affliction without a cure. Yet independent assessments of a recent clinical investigative trial in Vancouver

proved the company’s microcurrent electro-therapy technology was successful in mitigating AMD’s symptoms in those patients treated with the device.

The Nova Oculus device has been certified as complying with the quality management standard set by the International Organization of Standardization (ISO) and the electrical safety standard set by the International Electrotechnical Commission (IEC). These certifications make possible future global regulatory approvals for Nova Oculus.

Media Contact

Walter O’Rourke, Nova Oculus Partners, LLC, 1 647-204-3477, worourke@retinaltherapies.com

 

SOURCE Nova Oculus Partners, LLC



Source link
[ad_2]
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.

[ad_2]

PR Newswire

Recent Posts

Share repurchase programme

[ad_1] Nørresundby, 26 April 2024Announcement no. 23/2024 The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated…

4 days ago

Gyroscope Market Size, Share And Growth Analysis For 2024-2033

[ad_1] Gyroscope Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Gyroscope Global…

4 days ago

Casting Off the Caste System and its Stigma: Empowering the Forgotten Indigenous People of India with Human Rights

[ad_1] ODISHA, India, and LOS ANGELES, Calif., April 25, 2024 (SEND2PRESS NEWSWIRE) — In the 1880s, to call attention to…

4 days ago

Alipay+ Enables Digital Payment of 14 Overseas E-wallets from 9 Countries and Regions in Hong Kong to Support City’s Global Travel Drive

In support of Hong Kong's new mega tourism and commerce drive, Alipay+ now enables users of 14 leading overseas mobile…

4 days ago

Celebrate "Bleach: Brave Souls" Reaching Over 90 Million Downloads Worldwide with "The Future Society Zenith Summons: Cyber" Featuring New Versions of Ulquiorra, Orihime, and Nnoitora

[ad_2] TOKYO, April 26, 2024 /PRNewswire/ -- KLab Inc. announced that its hit 3D action game Bleach: Brave Souls has…

4 days ago

TransAlta Declares Dividends

[ad_1] CALGARY, Alberta, April 24, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of TransAlta Corporation (TSX: TA) (NYSE: TAC)…

5 days ago